BioSpace News Archive

A prominent leader in female health, Dr. Heather Furnas, of Allegro Medspa, is adding this first-of-its-kind treatment for women to her practice. Cliovana is the fastest growing, non-invasive female sexual wellness treatment in North America.

In September 2020 biotech start-up COVIMRO Ltd demonstrated the effectiveness of its food-grade compound, Covimro, against Coronavirus.

PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webinar in its deep dive series discussing the PTC518 Huntington disease (HD) program on Thursday, April 15 at 9 a.m. E.T.

Leading Canadian laboratory services provider partners with cyber security research community to strengthen security posture and further protect customer data

NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell therapies, today announced that it has appointed Philip Moody as its Chief Financial Officer (CFO)

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that it has been granted an exclusive sublicense to technology related to the use of novel and proprietary central nervous system (CNS) homing peptides for the therapeutic treatment of neuroinflammatory disease in cancer patients.

ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX), a clinical-stage biomedical company, today announced the publication of a peer reviewed research paper describing and interpreting the results examining the benefit provided by AAGP® to enable human induced pluripotent stem cell (iPSC) derived retinal precursor cells transplanted to restor vision in an experimental model of blindness due to retina degeneration

OneOncology, the national platform for independent community oncology practices, announced that Eastern Connecticut Hematology and Oncology ‘s Dinesh Kapur, MD has succeeded Natalie Dickson MD, president and chief medical officer, Tennessee Oncology as chair of OneCouncil, the partnership’s all-physician advisory board for clinical and strategic initiatives.

Strong Loyalty Among Subscribers: After Five Months, 74% of Key Customer Segment Remain Active Users Company Created New Product Category, Filling Market Gap Between Supplements and Prescription Drugs

In the largest study of its kind, Feinstein Institutes for Medical Research and Northwell COVID-19 Research Consortium researchers reveal blood clot risk and anticoagulation benefits in hospitalized coronavirus disease 2019 (COVID-19) patients who have been recently discharged from the hospital.